If you have been reading about Redox coenzyme and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-07-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Measuring NAD+ in biological samples requires care because the molecule is chemically reactive and present at low concentrations in some tissues. Common approaches include enzymatic cycling assays, high-performance liquid chromatography, and liquid chromatography coupled to mass spectrometry. Each method has different sensitivity and specificity, and sample preparation can affect results. Acidic or alkaline extraction steps are used in some protocols, but the choice depends on the analyte and matrix. No single method is universally optimal for every tissue or fluid.
Solid NAD+ is relatively stable when kept dry, cold, and protected from light. Aqueous solutions are more vulnerable to hydrolysis and can lose activity during repeated freeze-thaw cycles or prolonged storage at ambient temperature. Stability depends on pH, ionic strength, and the presence of degrading enzymes or metal ions. For many laboratory uses, aliquots are stored frozen and thawed only once. Exact degradation rates vary by matrix, so stability should be checked for each application rather than assumed.
Laboratory handling of NAD+ follows standard practices for hygroscopic fine chemicals. Personnel typically avoid inhalation and skin contact, use gloves and eye protection, and work in a ventilated area. Quality control may include ultraviolet absorbance at the nicotinamide maximum, chromatographic purity, water content, and identity confirmation by mass spectrometry. Because commercial preparations can contain counterions, residual solvents, or related nucleotides, a certificate of analysis helps verify the material. Researchers should confirm that the form supplied matches the intended assay.
In cells, NAD+ functions primarily as an electron carrier. Dehydrogenase enzymes in glycolysis and the citric acid cycle transfer hydride from substrates to NAD+, producing NADH. NADH then delivers electrons to the mitochondrial respiratory chain, supporting ATP synthesis. In fermentation, NADH is reoxidized to NAD+ so that glycolysis can continue. The balance between NAD+ and NADH helps set metabolic flux. Beyond redox, NAD+ serves as a substrate for enzymes that cleave it, including sirtuins, poly(ADP-ribose) polymerases, and CD38. These reactions consume NAD+ and release nicotinamide and ADP-ribose products.
Biosynthesis occurs through salvage, Preiss-Handler, and de novo pathways. In mammals, the salvage pathway from nicotinamide predominates, and NAMPT is often described as rate-limiting. Nicotinamide riboside and nicotinic acid enter related routes that converge on NAD+ production. Tissue NAD+ concentrations vary widely and are maintained by a balance of synthesis and consumption. Some studies report age-related declines in certain tissues, but whether these changes cause disease or can be reversed to improve human health remains an open question.
| Property | Value | Notes |
|---|---|---|
| UV absorbance maximum | ~259 nm | Nicotinamide ring; spectrum depends on pH. |
| Primary analytical method | LC-MS | Separates and identifies nucleotides with high specificity. |
| Alternative method | Enzymatic cycling | Amplifies signal for low-abundance samples. |
| Typical storage | −20 °C or below | Dry powder, desiccated and protected from light. |
| Degradation products | Nicotinamide and ADP-ribose | Hydrolysis products can interfere with assays. |
Beyond redox chemistry, NAD+ serves as a substrate for enzymes that cleave the molecule and transfer its ADP-ribose moiety or remove acetyl groups. Sirtuins consume NAD+ during deacetylation, poly(ADP-ribose) polymerases use it in DNA damage responses, and CD38 enzymes hydrolyze it to signaling metabolites. These consumption pathways mean that NAD+ availability can influence gene regulation, DNA repair, and calcium signaling. Cellular NAD+ concentrations decline in some tissues with age in animal models, but whether this decline is a cause or consequence of aging in humans remains an active open question.
Nicotinamide adenine dinucleotide, commonly abbreviated NAD+, is a dinucleotide coenzyme built from an adenine nucleotide and a nicotinamide nucleotide joined by a pyrophosphate linkage. Its oxidized form carries a positive charge on the nicotinamide ring, while the reduced form, NADH, carries a hydride equivalent. The molecule participates in hundreds of oxidoreductase reactions, where it accepts or donates electrons and protons. Because it can cycle between oxidized and reduced states without net consumption, NAD+ functions as a reusable electron carrier rather than a fuel molecule.
In glycolysis, the tricarboxylic acid cycle, and fatty acid oxidation, NAD+ is reduced to NADH at specific dehydrogenase steps. NADH then delivers electrons to the mitochondrial electron transport chain, mainly at complex I, supporting oxidative phosphorylation and ATP production. The balance between NAD+ and NADH, often expressed as a ratio, influences metabolic flux and redox homeostasis in different cellular compartments. Cytosolic and mitochondrial pools are connected but not identical, and their ratios can differ substantially because of compartment-specific enzymes and transport systems.
Beyond redox chemistry, NAD+ is consumed as a substrate by enzymes that transfer ADP-ribose or remove acetyl groups. Sirtuins use NAD+ in deacylation reactions, poly(ADP-ribose) polymerases use it in DNA damage responses, and CD38 hydrolases convert it to signaling metabolites. Because these enzymes compete for the same pool, changes in NAD+ availability can influence multiple cellular processes. The relative contribution of each consumption route differs by cell type and condition, and precise quantitative links remain an active area of study.
Research on NAD+ spans biochemistry, aging biology, and metabolism. Studies often examine how NAD+ levels change with age, diet, exercise, or disease states, and whether precursor supplementation alters those levels. Findings in animal models do not automatically translate to humans, and measurement methods vary across studies. Questions about tissue-specific effects, long-term consequences, and causal relationships remain open. NAD+ itself is not established as a single therapeutic agent with a broad clinical role.
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a coenzyme built from two nucleotides joined by a phosphate linkage. One nucleotide carries adenine, and the other carries nicotinamide; the plus sign denotes a formal positive charge on the nicotinamide ring, not a free proton. In cells, NAD+ and its reduced partner NADH form a reversible redox pair. That pair participates in electron transfer reactions throughout metabolism. The abbreviation NAD+ is common in biochemistry, while NAD(H) sometimes denotes the combined pool.
The molecule was first described in the early twentieth century as a factor that promoted fermentation in yeast extracts. Later work linked it to hydrogen transfer and to the oxidation of nutrients in living tissues. Its structure was resolved as a dinucleotide, which explained why it could accept and donate electrons at specific enzyme sites. Today, NAD+ is recognized as a central substrate and signaling precursor, not merely a metabolic cofactor. Whether all observed NAD+ changes reflect causal signaling remains an open question.
== See also == First 100 days of the second Trump presidency – Period from January to April 2025 List of executive actions by Donald Trump Lists of presidential trips made by Donald Trump (international trips) Second presidential transition of Donald Trump – Transfer of presidential power from Joe Biden to Donald Trump Timeline of the 2024 United States presidential election
==== Top leaders' comments ==== AQSIQ announced the revocation of all exemptions from inspection previously granted to dairy producers, who were asked to cease citing the privilege in their advertisements. The State Council ordered an overhaul of the dairy industry, and promised to provide free medical care to those affected. Formally, the State Council released its initial findings, and a top-level official apology of the incident both came on 21 September. Wen Jiabao apologised while visiting victims in hospitals.
This failure to deaminate the AMP molecules has three major effects. First, significant amounts of AMP are lost from the cell and the body. Second, ammonia is not freed when the cell does work. Third, the level of IMP in the cell is not maintained.
==== Eliminated in primary ==== James Barbee, business owner Jason Corley, Lubbock County commissioner (2019–present) and candidate for this district in 2016 Donald May, surgeon and candidate for this district in 2003, 2014, and 2016 Matt Smith, roofing company owner Ryan Zink, convicted felon, participant in the January 6 United States Capitol attack, and candidate for this district in 2024
Sources: en.wikipedia.org
== Neurotransmitter systems == Neurons expressing certain types of neurotransmitters sometimes form distinct systems, where activation of the system affects large volumes of the brain, called volume transmission. Major neurotransmitter systems include the noradrenaline (norepinephrine) system, the dopamine system, the serotonin system, and the cholinergic system, among others. Trace amines have a modulatory effect on neurotransmission in monoamine pathways (i.e., dopamine, norepinephrine, and serotonin pathways) throughout the brain via signaling through trace amine-associated receptor 1. A brief comparison of these systems follows:
However, Erasmas and several non-avout companions, with Fraa Jad's tacit agreement, decide to seek out Orolo. After a dangerous journey over the planet's frozen pole, they reunite with Orolo at an archaeological excavation of Orithena, an ancient concent destroyed by volcanic eruption. Orolo holds philosophical discussions with Erasmas about the nature of the cosmos and consciousness, and how he believes that the aliens are not simply from another planet, but from another cosmos that is influenced by Arbre. During one of the discussions, a small spacecraft lands in Orithena on an ancient analemma symbol within the excavation. (It is later revealed that Orolo had transmitted the analemma symbol to the spaceship and anticipated the landing at Orithena.) A female alien's body is found on board, dead of a recent gunshot wound. She has brought with her four vials of blood – one for each of four alien races – and evidence about their technology. Shortly thereafter, the aliens propel a massive metal rod at the volcano, triggering an eruption that destroys Orithena. Orolo sacrifices his life to ensure the recovery of the dead alien's remains and her blood samples, an event that leads to his canonization as Saunt Orolo. Erasmas travels to Saunt Tredegarh where he attends the Convox dedicated to dealing with the military, political, and technical issues raised by the existence of the alien ship in Arbre's orbit. Research is conducted on the samples from Orithena, and the aliens are found to come from planets in four parallel and distinct cosmi: Urnud, Tro, Laterre and Fthos.
According to physician Robert Barouki (2023), research on women's health has historically been limited by social bias and an emphasis on male physiology. French geneticist Claudine Junien noted in 2016 that France lagged behind other countries in integrating sex-based biological differences in research and treatment, though attention to gender parity in healthcare was increasing.
On 27 August 2025, President Luiz Inácio Lula da Silva signed Decree No. 12,595/2025, establishing the DTV+ system (also called TV 3.0) as the new standard for Brazilian free-to-air television, based on ATSC 3.0. The standard covers physical, transport, video, audio, subtitles and emergency alert layers. The preparatory phase is expected to be completed in 2025, with the first TV 3.0 transmissions beginning in the first half of 2026 in major capitals. The expansion process to reach coverage across the entire national territory is estimated to take up to 15 years. The system also incorporates internet integration, greater interactivity, accessibility and public services via the television platform. The signing of the decree followed years of studies, research, discussions and debates led by the MCom, involving companies in the sector, academics and specialists. Following the regulation, Brazilian broadcasters may begin implementing the new system. According to the minister of communications, Frederico Siqueira, the signing of the decree marked a historic moment for Brazil, strengthening free-to-air television as a democratic and popular meeting space. He highlighted that TV 3.0 will not change a central principle: free access. The new technology will modernize Brazilian digital television, offering 4K and 8K images, immersive sound, greater interactivity and integration with the internet. The goal is to provide a richer and more personalized experience for viewers, bringing free-to-air television closer to streaming services.
=== Discontinued === ABT-436 – vasopressin V1b receptor antagonist – alcoholism Adrogolide (ABT-431; DAS-431) – dopamine D1 receptor agonist – cocaine-related disorders ADX-629 – aldehyde inhibitor / reactive aldehyde species (RASP) inhibitor – alcoholism, alcoholic hepatitis ADX-10061 (CEE-310; CEE-03-310; NNC-010687; NNC-687) – dopamine D1 receptor antagonist – smoking withdrawal, substance-related disorders ADX-71441 – GABAB receptor positive allosteric modulator – alcoholism, cocaine-related disorders, substance-related disorders Anatabine (RCP-006) – nicotinic acetylcholine receptor agonist – smoking withdrawal ANS-6637 (GS-6637; GS-6673) – aldehyde dehydrogenase 2 (ALDH2) inhibitor – alcoholism, opioid-related disorders, smoking withdrawal, substance-related disorders Arbaclofen placarbil (R-baclofen placarbil; XP-19986) – GABAB receptor agonist – alcoholism ASP-8062 – GABAB receptor modulator – opioid-related disorders Aticaprant (AVTX-501; CERC-501; JNJ-3964; JNJ-67953964; JNJ-67953964-AAA; LY-2456302) – κ-opioid receptor antagonist – alcoholism, cocaine-related disorders, smoking withdrawal Azasetron (nazasetron; Serotone; Y-25130) – serotonin 5-HT3 receptor antagonist – cocaine-related disorders AZD-4041 – orexin OX1 receptor antagonist – smoking withdrawal Baclofen/samidorphan (ALKS-29; ALKS-33/baclofen; baclofen/ALKS-33) – combination of baclofen (GABAB receptor agonist) and samidorphan (μ-opioid receptor antagonist) – alcoholism Befloxatone (MD-370503) – monoamine oxidase A (MAO-A) inhibitor – smoking withdrawal BP-897 – dopamine D3 receptor agonist – cocaine-related disorders BR-9003 (BR-9003A) – undefined mechanism of action – smoking withdrawal BTRX-246040 (LY-2940094) – nociceptin receptor agonist – alcoholism Buprenorphine/naloxone (NanoBUP; NTC-0510; NTC-510) – combination of buprenorphine (non-selective opioid receptor modulator) and naloxone (orally/sublingually inactive opioid receptor antagonist) – opioid-related disorders Buprenorphine/samidorphan (ALKS 33-BUP; ALKS 33/buprenorphine; ALKS-5461; BUP-ALKS 33; buprenorphine/ALKS-33; buprenorphine/RDC 0313; RDC 0313/buprenorphine; samidorphan/buprenorphine) – combination of buprenorphine (non-selective opioid receptor modulator) and samidorphan (μ-opioid receptor antagonist) – cocaine-related disorders Cannabidiol (CBD; synthetic cannabidiol; RAD-011) – cannabinoid/various actions – substance-related disorders CVL-936 – dopamine D2 and D3 receptor antagonist – substance-related disorders CX-1739 – AMPA receptor positive allosteric modulator (ampakine) – substance-related disorders Deudimethyltryptamine (HLP004; HLP-004; CYB004; CYB-004; DMT-d10; deuterated dimethyltryptamine; dDMT) – non-selective serotonin receptor agonist, serotonin 5-HT2A receptor agonist, and serotonergic psychedelic – substance-related disorders Deupsilocin (HLP003; HLP-003; CYB003; CYB-003; psilocin-d10; deuterated psilocin) – non-selective serotonin receptor agonist, serotonin 5-HT2A receptor agonist, and serotonergic psychedelic – alcoholism Dianicline (SSR-591813) – nicotinic acetylcholine receptor agonist – smoking withdrawal Drinabant (AVE-1625; INDV-5004; OPNT-004) – cannabinoid CB1 receptor antagonist – substance-related disorders Ecopipam (EBS-101; PSYRX-101; SCH-39166) – dopamine D1 receptor antagonist – cocaine-related disorders Eglumetad (eglumegad; LY-354740) – metabotropic glutamate mGlu2 and mGlu3 receptor agonist – smoking withdrawal Elinzanetant (BAY-3427080; GSK-1144814A; GSK-1144814; Lynkuet; NT-814) – neurokinin NK1 and NK3 receptor antagonist – opioid-related disorders Femoxetine (femoxitine; FG-4963; Malexil; NNC-204963) – selective serotonin reuptake inhibitor (SSRI) – alcoholism Gabapentin enacarbil (ASP8825; Gabapentin-XP; GSK-1838262; Horizant; Regnite; Solzira; XP13512) – gabapentinoid (α2δ subunit-containing voltage-gated calcium channel blocker) – alcoholism Gepirone (Ariza; BMY-13805; Exxua; MJ-13805; Org-33062; TGFK07AD; Travivo; Variza) – serotonin 5-HT1A receptor agonist – cocaine-related disorders Istradefylline (KW-6002; Nourianz; Nouriast) – adenosine A2 receptor antagonist ITI-333 – serotonin 5-HT2A receptor antagonist, dopamine D1 receptor antagonist, α1A-adrenergic receptor antagonist, μ-opioid receptor partial agonist – substance-related disorders JNJ-39393406 – α7 subunit-containing nicotinic acetylcholine receptor positive allosteric modulator – smoking withdrawal JZP-150 – fatty acid amide hydrolase (FAAH) inhibitor – alcoholism Lisdexamfetamine (LDX; Elvanse; NRP-104; S-877489; SHP-489; SPD-489; Tyvense; Venvanse; Vyvanse) – norepinephrine–dopamine releasing agent (NDRA) – cocaine-related disorders Lorcaserin (APD-356; Belviq; E2023; Venespri) – serotonin 5-HT2C receptor agonist – smoking withdrawal Manifaxine (BW-1555U88; GW-320659) – norepinephrine–dopamine reuptake inhibitor (NDRI) – smoking withdrawal Mavoglurant (AFQ-056; STP-7) – metabotropic glutamate mGlu5 receptor antagonist – smoking withdrawal Nalmefene (CPH-101; JF-1; Lu AA36143; Nalmetrene; NIH-10365; ORF-11676; Selincro; Soberal) – μ-opioid receptor antagonist, κ-opioid receptor weak partial agonist – smoking withdrawal Nepicastat oral (APL-1401; SYN-117) – dopamine β-hydroxylase (DBH) inhibitor – cocaine-related disorders Neramexane (KRP-209; MRZ-2/579) – NMDA receptor antagonist, nicotinic acetylcholine receptor antagonist – alcoholism NIC-002 (NIC002; CYT002-NicQβ; Nicotine-Qβ) – immunostimulant (nicotine vaccine) – smoking withdrawal NicVAX – immunostimulant (nicotine vaccine) – smoking withdrawal Nornicotine – nicotinic acetylcholine receptor agonist – smoking withdrawal NS-2359 (GSK-372475) – serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) – alcoholism NYX-783 – ionotropic glutamate NMDA receptor modulator – alcoholism, opioid-related disorders OREX-1019 – μ-opioid receptor agonist, δ-opioid receptor antagonist, κ-opioid receptor antagonist, nociceptin receptor agonist – cocaine-related disorders OREX-1038 – μ-opioid receptor agonist – cocaine-related disorders, opioid-related disorders Oxytocin intranasal (Syntocinon Nasal Spray; TUR-001) – oxytocin receptor agonist – alcoholism Quetiapine (FK-949; FK949E; ICI-204636; Seroquel) – atypical antipsychotic (non-selective monoamine receptor modulator) – alcoholism Rimonabant (Acomplia; SR-141716; SR-141716A; Zimulti) – cannabinoid CB1 receptor antagonist – smoking withdrawal Risperidone (JNJ-410397-AAA; R-64766; R064766; Risperdal; Risperdal Consta; Risperdal Depot) – atypical antipsychotic (non-selective monoamine receptor modulator) – substance-related disorders RTI-113 – dopamine reuptake inhibitor (DRI) (cocaine analogue) – cocaine-related disorders Samidorphan (ALKS-33; RDC-0313; RDC-0313-00) – μ-opioid receptor antagonist – alcoholism, substance-related disorders Sembragiline (EVT-302; RG-1577; RO-4602522) – monoamine oxidase B (MAO-B) inhibitor – smoking withdrawal Serlopitant (JTS-661; MK-0594; VPD-737) – neurokinin NK1 receptor antagonist – alcoholism Surinabant (SR-147778; SR147778) – cannabinoid CB1 receptor antagonist – alcoholism, smoking withdrawal TA-NIC – immunostimulant (nicotine vaccine) – smoking withdrawal Tradipitant (LY-686017; Nereus; VLY-686) – neurokinin NK1 receptor antagonist – alcoholism Verucerfont (GSK-561679; NBI-77860) – corticotropin-releasing factor 1 (CRF1) receptor antagonist Vigabatrin (γ-vinyl-GABA; gamma-vinyl-GABA; GVG; M071754; MDL-71754; RMI-71754; Sabril; Sabrilex) – GABA transaminase (GABA-T) inhibitor – cocaine-related disorders, substance-related disorders
Sources: en.wikipedia.org
Muscimol, also known as agarin, pantherine, or pyroibotenic acid, is a GABAA receptor agonist with sedative and hallucinogenic effects and the principal psychoactive constituent of Amanita mushrooms such as Amanita muscaria (fly agaric) and Amanita pantherina (panther cap). It is a 3-hydroxyisoxazole alkaloid and is closely related structurally to the neurotransmitter γ-aminobutyric acid (GABA). The compound is widely used as a ligand and agonist of the GABAA receptor in scientific research. Muscimol is typically taken orally, but may also be smoked. Peak effects occur after 1 to 3 hours orally and its duration is 4 to 10 hours but up to 24 hours. The effects of muscimol in humans include central depression, sedation, sleep, cognitive and motor impairment, hallucinations, perceptual distortion, and muscle twitching, among others. Muscimol acts as a potent GABAA receptor full agonist. However, it acts as a preferential supra-maximal agonist at extrasynaptic δ subunit-containing GABAA receptors. It is also a potent GABAA-ρ receptor partial agonist and a weak GABA reuptake inhibitor. The drug is inactive at the GABAB receptor but is a substrate of GABA transaminase (GABA-T). Muscimol mostly exerts its effects via GABAA receptor activation. It is very different from drugs like benzodiazepines and barbiturates as it is an orthosteric agonist of the GABAA receptor rather than an allosteric modulator. Unlike GABA, muscimol crosses the blood–brain barrier and hence is centrally active. Muscimol is a conformationally restrained analogue of GABA.
Because DNA collects mutations over time, which are then inherited, it contains historical information, and, by comparing DNA sequences, geneticists can infer the evolutionary history of organisms, their phylogeny. This field of phylogenetics is a powerful tool in evolutionary biology. If DNA sequences within a species are compared, population geneticists can learn the history of particular populations. This can be used in studies ranging from ecological genetics to anthropology.
A Ukrainian international law scholar, Alexander Merezhko, has developed a project called the International Convention on Prohibition of Cyberwar in Internet. According to this project, cyberwar is defined as the use of Internet and related technological means by one state against the political, economic, technological and information sovereignty and independence of another state. Professor Merezhko's project suggests that the Internet ought to remain free from warfare tactics and be treated as an international landmark. He states that the Internet (cyberspace) is a "common heritage of mankind". On the February 2017 RSA Conference Microsoft president Brad Smith suggested global rules – a "Digital Geneva Convention" – for cyber attacks that "ban the nation-state hacking of all the civilian aspects of our economic and political infrastructures". He also stated that an independent organization could investigate and publicly disclose evidence that attributes nation-state attacks to specific countries. Furthermore, he said that the technology sector should collectively and neutrally work together to protect Internet users and pledge to remain neutral in conflict and not aid governments in offensive activity and to adopt a coordinated disclosure process for software and hardware vulnerabilities. A fact-binding body has also been proposed to regulate cyber operations.
American biochemist of Ukrainian-Jewish origin, who discovered metabolic regulation by feedback inhibition. Henry Berkeley Franks (Hal) Dixon (1928–2008). British enzymologist at the University of Cambridge. Malcolm Dixon FRS (1899–1985). British biochemist at the University of Cambridge. Research on enzyme structure, kinetics, and properties. His book (with Edwin C. Webb) Enzymes was very influential.
Sources: en.wikipedia.org
Common laboratory methods include enzymatic cycling, high-performance liquid chromatography, and liquid chromatography with mass spectrometry. The choice depends on sample type, expected concentration, and available equipment.
Frozen storage slows hydrolysis and other degradation reactions that occur more quickly in solution at warmer temperatures. Dry powder is generally more stable than aqueous solutions, which can lose activity over time.
Purity tests can reveal related nucleotides, water content, counterions, and other impurities that may affect an experiment. They do not by themselves establish biological activity or suitability for a specific assay.
Nicotinamide adenine dinucleotide, with the plus sign indicating the oxidized form. It is a coenzyme present in all living cells. The reduced form is NADH.